Sunday, October 2, 2022
-Advertisement-
-Advertisement-
Tech ObserverNewsIndustryCEO of top Covid-19 vaccine manufacturer Pfizer tests positive

CEO of top Covid-19 vaccine manufacturer Pfizer tests positive

Chairman and CEO Albert Bourla said Monday that he started taking Pfizer's Paxlovid pill treatment and is isolating while he recovers.

Chairman and CEO Albert Bourla said Monday that he started taking Pfizer's Paxlovid pill treatment and is isolating while he recovers.

Even as the Covid-19 cases continue to remain low globally following ramp up by top manufacturers globally, in an ironic turn of events top executive at Pfizer, a leading producer of Covid-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms.

Chairman and CEO Albert Bourla said Monday that he started taking Pfizer’s Paxlovid pill treatment and is isolating while he recovers.

Bourla has received four shots of Comirnaty, the COVID-19 vaccine developed by the New York drugmaker along with BioNTech. He said in a brief statement issued by the company that he is confident of a quick recovery.

So far more than 128 million people in the United States have become fully vaccinated with Pfizer’s two-shot vaccine since it entered the market more than a year ago and almost 61 million have received an initial booster shot, according to the Centers for Disease Control and Prevention.

Scientists say the vaccine still offers solid protection against hospitalization and serious illness. But the evolving virus has made it tougher for vaccines to prevent all forms of illness from developing.

Pfizer and another vaccine maker, , are updating their shots to provide protection against newer versions of the virus for a fall booster campaign.
Paxlovid also has shown in research to be extremely effective at warding off serious illness if it is administered shortly after symptoms start.

Comirnaty and Paxlovid are the top-selling COVID-19 vaccine and treatment on the market. Combined, they brought in nearly USD 17 billion in sales for Pfizer during the recently completed second quarter.

Subscribe to receive the day's headlines from Tech Observer straight in your inbox

- Advertisement -

Your Comment on this Story

Comments

Share on activity feed

Powered by WP LinkPress

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Subscribe to our Newsletter

83000+ Industry Leaders read it everyday

By subscribing you agree to our Privacy Policy, T&C and consent to receive newsletters and other important communications.
- Advertisement -ESDS SAP HANA Community Cloud
- Advertisement -

RELATED ARTICLES

- Advertisement -